NCT02116907View on ClinicalTrials.gov

An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy Subjects

Interventions

DRUG

E2007

14C-labeled perampanel dissolved in ethanol and administered using a capsule formulation in a single dose, one day

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT02116907 - An Open-Label, Single-Dose Study to Determine the Metabolism and Elimination of 14C-Perampanel in Healthy Male Subjects | Biotech Hunter | Biotech Hunter